Analysis of the impact of centralized procurement policy on the utilization of breast cancer treatment drugs in a specialized cancer hospital
10.3969/j.issn.1671-332X.2025.07.003
- VernacularTitle:集采政策对肿瘤专科医院乳腺癌治疗药品使用的影响
- Author:
Min XU
1
;
Jie NING
1
;
Xue XIA
1
;
Yanan SU
1
;
Chuhan XIE
1
;
Xiaoqian DING
1
Author Information
1. 中山大学肿瘤防治中心//华南恶性肿瘤防治全国重点实验室 广东 广州 510060
- Publication Type:Journal Article
- Keywords:
Centralized drug procurement;
Breast cancer;
Oncology;
Drugs
- From:
Modern Hospital
2025;25(7):995-997
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the impact of the National Centralized Drug Procurement Policy(hereinafter referred to as the"centralized procurement policy")on the utilization of breast cancer treatment drugs in a specialized cancer hospital.Methods The defined daily dose(DDD)method was used to compare the daily drug cost(DDC),drug utilization frequency(DDDs),and affordability of letrozole,anastrozole,and capecitabine before and after the implementation of the centralized pro-curement policy in a tertiary specialized cancer hospital in Guangzhou.Results and Conclusion After the policy implementa-tion,the DDC of all three drugs decreased.The out-of-pocket DDC for the selected drugs remained stable or decreased,while the out-of-pocket DDC for both originator drugs and generic drugs increased,with a more pronounced increase for originator drugs.The proportion of DDDs for the selected drugs increased post-policy.The centralized procurement policy not only reduced the prices of selected drugs but also drove down the prices of generic and originator drugs.It is recommended to further expand the scope of centralized procurement for anticancer drugs and the types of cancers covered,as well as to establish a transitional mech-anism for medical insurance payment standards.
